Skip to content 
Two key appointments set the stage for market disruption: Chris Wright’s energy agenda is expected to boost fossil fuels and nuclear innovation, while Robert F. Kennedy Jr.’s oversight signals disruption for biotech and pharmaceuticals. Last week’s developments could reshape entire sectors. Dive in to uncover the opportunities and risks that lie ahead.
Market Overview
Over the past week, U.S. equity markets saw a sharp reversal, with all major indices posting significant losses. The Russell 2000 led the declines, tumbling 3.99%, reflecting heightened volatility in small-cap stocks. The tech-heavy Nasdaq wasn’t far behind, dropping 3.47% amid fears of a softening chip sector and concerns over stretched valuations.
The S&P 500 fell 2.12%, weighed down by hawkish Federal Reserve commentary, while the Dow Jones proved relatively resilient but still lost 1.26% over the week.
Investor sentiment was shaped by Federal Reserve Chair Jerome Powell’s remarks that tempered expectations for near-term rate cuts. Powell’s insistence that the economy isn’t signaling urgency for monetary easing dampened hopes for a December rate cut, with market-implied probabilities dropping from 85% to 60%. Rising Treasury yields added further pressure, with the 10-year benchmark climbing to 4.51%, its highest level since June.
Additionally, sector rotation emerged as financials and energy gained on deregulation hopes, while healthcare and EV stocks declined on policy uncertainties tied to the incoming administration. The market’s frothy positioning, coupled with these crosscurrents, has left equities vulnerable to further downside correction.
Last Week’s Highlights
- Inflation Accelerates: U.S. inflation rose 0.2% in October, pushing the annual rate to 2.6% as housing costs stayed high.
- Powell’s Hawkish Tone: Fed Chair Powell dashed hopes for a December rate cut, with market odds dropping to 60% from 85%.
- 10-Year Yields Peak: The 10-year Treasury yield hit 4.5%, its highest since June, signaling tighter financial conditions.
- Retail Sales Up: U.S. retail sales rose 0.4% in October, beating forecasts and showing consumer resilience before holidays.
- Healthcare Slump: Biotech stocks plunged after Robert F. Kennedy Jr. was named HHS nominee, raising regulatory fears.
- Chip Sector Hit: Weak Applied Materials guidance sent semiconductor stocks (SMH) down 7.5%, heightening Nvidia earnings concerns.
- Tesla Swings: Tesla soared 39% post-election but retraced 8% as plans to end the $7,500 EV tax credit were confirmed.
- Bitcoin Rallies: Bitcoin surged 32% post-election, driven by optimism over looser crypto regulation under Trump.
- ECB Holds Caution: The ECB emphasized downside risk insurance despite an October rate cut, signaling a cautious stance.
- UK GDP Slows: UK GDP grew just 0.1% in Q3, missing forecasts, as manufacturing and services weakened.
- China Stocks Drop: The Shanghai Composite slid 3.5%, pressured by deflation concerns and potential U.S. tariffs.
- Yen Weakens: The yen fell to 155 per dollar on Trump’s trade policies and Japan’s slower Q3 GDP growth of 0.2%.
- Mexico Eases Rates: Mexico cut its policy rate to 10.25%, citing easing core inflation and economic headwinds.
- Oil Declines: Crude oil fell 4.8% to $67.02 on weak demand prospects tied to China’s lower-than-expected stimulus measures.
- Gold Falls: Gold prices dropped 4.5% to $2,563 as Bitcoin and rising treasury yields temporarily compete with the metal.
Week Ahead & Implications
Trump’s Energy Appointment: Chris Wright
The appointment of Chris Wright as Secretary of Energy signals a major pivot toward aggressive fossil fuel expansion under the Trump administration. Wright, a staunch supporter of fracking and traditional energy dominance, has pledged to restore American energy independence, including accelerating the replenishment of the Strategic Petroleum Reserve (SPR) and reducing restrictions on liquefied natural gas (LNG) exports. This appointment will likely lead to significant upside for U.S. energy companies, particularly those involved in oil and gas production.
Expect a bullish push for energy stocks – watch out for undervalued fracking and midstream energy companies as beneficiaries of the political tailwind. However, be wary of potential retaliation from global competitors such as OPEC countries, which could inject volatility into the energy market.
Biotech and Pharma Face Uncertainty Under RFK Jr. Oversight
President-elect Trump’s nomination of Robert F. Kennedy Jr. as Secretary of Health and Human Services casts a shadow over the pharmaceutical and biotech sectors. Kennedy’s outspoken criticism of the industry, particularly regarding vaccine practices, raises concerns about potential regulatory shake-ups.
While vaccine makers like Moderna and BioNTech are already reeling, the implications could extend to the broader biotech innovation and drug approval process, with companies facing heightened scrutiny on pricing, transparency and research standards. Investors should be prepared for volatility across the sector, with mid-cap biotechs appearing to be the most exposed.
A shift to large-cap pharmaceuticals, which are less dependent on speculative biotech valuations, or diversified healthcare ETFs could provide more stable returns in the face of such uncertainty.
Russia’s Uranium Export Restrictions Fuel U.S. Nuclear Momentum
Russia’s restriction on uranium exports to the U.S. has exposed critical vulnerabilities in the nation’s nuclear energy supply chain, as nuclear power generates 20% of U.S. electricity. With Russia controlling nearly half of global uranium enrichment capacity and providing over a quarter of U.S. enriched uranium (see chart below), this move amplifies the urgency for energy security.
The Biden administration’s multibillion-dollar efforts to expand domestic uranium enrichment are underway, but with only one operational facility (Urenco Ltd.), short-term supply disruptions are likely.
This backdrop is highly favorable for uranium miners like Cameco and enrichment firms such as Centrus Energy, which are positioned to benefit from rising prices and increased federal support. Additionally, the appointment of Chris Wright as Energy Secretary under the Trump administration strengthens the focus on domestic energy independence.
Wright, known for his leadership in energy innovation, also serves on the board of nuclear startup OKLO, which specializes in small modular reactors (SMRs)—a promising solution for scalable, clean energy.
UK Inflation and Consumer Spending: The Week’s Defining Metrics
This week’s dual data releases—October UK Consumer Price Index (CPI) on Wednesday and UK retail sales on Friday—will provide key insights into inflationary pressures and consumer resilience. CPI is forecast to rise to 2.2% year-over-year (YoY) from September’s 1.7%, driven by Ofgem’s 9.5% energy price hike and diminishing base effects from last year’s utility price cuts.
Core inflation is expected to edge lower to 3.1%, suggesting some easing in underlying pressures. Retail sales are projected to contract by 0.2% month-over-month (MoM), reflecting the impact of higher energy bills and consumer caution.
These data releases are unlikely to shift the Bank of England’s (BoE) cautious stance, with December rate cut odds already below 20%. The expected CPI rise reflects temporary energy price adjustments rather than persistent inflationary pressures, limiting its effect on monetary policy. Retail sales, if weaker than expected, could reinforce concerns over slowing consumer demand, pressuring the pound and supporting gilts.
Bitcoin Rally Highlights Crypto Regulatory Changes
Bitcoin’s explosive 32% rally since Trump’s election reflects optimism about deregulation under his administration. The anticipated loosening of crypto oversight, particularly with Elon Musk’s advisory role, has reignited institutional interest in digital assets. However, this momentum has been accompanied by excessive froth in altcoins, suggesting speculative overextension.
In the near term, bitcoin could test new highs as institutional investors position for a friendlier regulatory environment. However, longer-term sustainability will depend on concrete policy outcomes rather than speculative fervor.
Investors should consider increasing their exposure to bitcoin via established ETFs (IBIT) or directly on dips, while avoiding smaller altcoins that remain highly vulnerable to corrections or outright fraud. Diversification into blockchain infrastructure or trading companies (COIN) could also provide attractive, but volatile, returns as the regulatory environment evolves.
Most Impactful Events to Watch Next Week
